Search

Displaying results 21 - 30 of 46 in total
  1. Indication

    Metastatic Esophageal Squamous Cell Carcinoma

    go.drugbank.com/conditions/DBCOND0054799
    Drugs: Hyaluronidase (human recombinant) · Ipilimumab · Nivolumab · Tislelizumab
  2. Indication

    Chronic Inflammatory Demyelinating Polyradiculoneuropathy

    go.drugbank.com/conditions/DBCOND0030996
    Drugs: Efgartigimod alfa · Human immunoglobulin G · Hyaluronidase (human recombinant)
  3. Indication

    Drug Extravasation

    go.drugbank.com/conditions/DBCOND0029080
    Drugs: Dexrazoxane · Hyaluronidase (human recombinant)
  4. Indication

    Unresectable, advanced Esophageal Squamous Cell Carcinoma (ESCC)

    go.drugbank.com/conditions/DBCOND0145163
    Drugs: Hyaluronidase (human recombinant) · Ipilimumab · Nivolumab
  5. Indication

    Metastatic Gastric Cancers

    go.drugbank.com/conditions/DBCOND0063580
    Drugs: Hyaluronidase (human recombinant) · Nivolumab · Trifluridine
  6. Indication

    Inflammatory Breast Cancer (IBC)

    go.drugbank.com/conditions/DBCOND0084733
    Drugs: Hyaluronidase (human recombinant) · Pertuzumab · Trastuzumab
  7. Indication

    Locally Advanced Urothelial Cancer

    go.drugbank.com/conditions/DBCOND0113982
    Drugs: Enfortumab vedotin · Hyaluronidase (human recombinant) · Nivolumab
  8. Indication

    Resectable Non-small Cell Lung Cancer

    go.drugbank.com/conditions/DBCOND0068626
    Drugs: Durvalumab · Hyaluronidase (human recombinant) · Nivolumab · Pembrolizumab
  9. Indication

    Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN)

    go.drugbank.com/conditions/DBCOND0144294
    Drugs: Cetuximab · Hyaluronidase (human recombinant) · Nivolumab · Pembrolizumab
  10. Indication

    Metastatic Esophageal Adenocarcinoma

    go.drugbank.com/conditions/DBCOND0125777
    Drugs: Hyaluronidase (human recombinant) · Nivolumab · Tislelizumab · Zanidatamab